Rich Pharmaceuticals, Inc. filed its 10-K on Sep 17, 2015 for the period ending Mar 31, 2015. In this report its auditor, KLJ & Associates, LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Rich Pharmaceuticals, Inc.
Equities
RCHA
US76303T4076
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+7.49% | 114B | |
+9.19% | 104B | |
-1.28% | 22.57B | |
-11.56% | 22.5B | |
-10.44% | 17.95B | |
-41.90% | 16.48B | |
-14.70% | 15.82B | |
+2.38% | 13.55B | |
+27.83% | 10.99B |